Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes

Karin Åvall, Yusuf Ali, Ingo B. Leibiger, Barbara Leibiger, Tilo Moede, Meike Paschen, Andrea Dicker, Elisabetta Daré, Martin Köhler, Erwin Ilegems, Midhat H Abdulreda, Mark Graham, Rosanne M. Crooke, Vanessa S Y Tay, Essam Refai, Stefan K. Nilsson, Stefan Jacob, Lars Selander, Per Olof Berggren, Lisa Juntti-Berggren

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<inf>i</inf>) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca<sup>2+</sup>]<inf>i</inf> response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)E2611-E2619
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number20
DOIs
StatePublished - May 19 2015

Fingerprint

Apolipoprotein C-III
Insulin Resistance
Type 2 Diabetes Mellitus
Inflammation
Apolipoproteins
Islets of Langerhans
Apoptosis
Glucose

Keywords

  • ApoCIII
  • Diabetes
  • Insulin resistance
  • Pancreatic islets

ASJC Scopus subject areas

  • General

Cite this

Åvall, K., Ali, Y., Leibiger, I. B., Leibiger, B., Moede, T., Paschen, M., ... Juntti-Berggren, L. (2015). Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes. Proceedings of the National Academy of Sciences of the United States of America, 112(20), E2611-E2619. https://doi.org/10.1073/pnas.1423849112

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes. / Åvall, Karin; Ali, Yusuf; Leibiger, Ingo B.; Leibiger, Barbara; Moede, Tilo; Paschen, Meike; Dicker, Andrea; Daré, Elisabetta; Köhler, Martin; Ilegems, Erwin; Abdulreda, Midhat H; Graham, Mark; Crooke, Rosanne M.; Tay, Vanessa S Y; Refai, Essam; Nilsson, Stefan K.; Jacob, Stefan; Selander, Lars; Berggren, Per Olof; Juntti-Berggren, Lisa.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 20, 19.05.2015, p. E2611-E2619.

Research output: Contribution to journalArticle

Åvall, K, Ali, Y, Leibiger, IB, Leibiger, B, Moede, T, Paschen, M, Dicker, A, Daré, E, Köhler, M, Ilegems, E, Abdulreda, MH, Graham, M, Crooke, RM, Tay, VSY, Refai, E, Nilsson, SK, Jacob, S, Selander, L, Berggren, PO & Juntti-Berggren, L 2015, 'Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes', Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 20, pp. E2611-E2619. https://doi.org/10.1073/pnas.1423849112
Åvall, Karin ; Ali, Yusuf ; Leibiger, Ingo B. ; Leibiger, Barbara ; Moede, Tilo ; Paschen, Meike ; Dicker, Andrea ; Daré, Elisabetta ; Köhler, Martin ; Ilegems, Erwin ; Abdulreda, Midhat H ; Graham, Mark ; Crooke, Rosanne M. ; Tay, Vanessa S Y ; Refai, Essam ; Nilsson, Stefan K. ; Jacob, Stefan ; Selander, Lars ; Berggren, Per Olof ; Juntti-Berggren, Lisa. / Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 20. pp. E2611-E2619.
@article{c70f9a6a6a3947abbd71cc8f924e10b9,
title = "Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes",
abstract = "Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca2+ concentration ([Ca2+]i) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca2+]i response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.",
keywords = "ApoCIII, Diabetes, Insulin resistance, Pancreatic islets",
author = "Karin {\AA}vall and Yusuf Ali and Leibiger, {Ingo B.} and Barbara Leibiger and Tilo Moede and Meike Paschen and Andrea Dicker and Elisabetta Dar{\'e} and Martin K{\"o}hler and Erwin Ilegems and Abdulreda, {Midhat H} and Mark Graham and Crooke, {Rosanne M.} and Tay, {Vanessa S Y} and Essam Refai and Nilsson, {Stefan K.} and Stefan Jacob and Lars Selander and Berggren, {Per Olof} and Lisa Juntti-Berggren",
year = "2015",
month = "5",
day = "19",
doi = "10.1073/pnas.1423849112",
language = "English (US)",
volume = "112",
pages = "E2611--E2619",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "20",

}

TY - JOUR

T1 - Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes

AU - Åvall, Karin

AU - Ali, Yusuf

AU - Leibiger, Ingo B.

AU - Leibiger, Barbara

AU - Moede, Tilo

AU - Paschen, Meike

AU - Dicker, Andrea

AU - Daré, Elisabetta

AU - Köhler, Martin

AU - Ilegems, Erwin

AU - Abdulreda, Midhat H

AU - Graham, Mark

AU - Crooke, Rosanne M.

AU - Tay, Vanessa S Y

AU - Refai, Essam

AU - Nilsson, Stefan K.

AU - Jacob, Stefan

AU - Selander, Lars

AU - Berggren, Per Olof

AU - Juntti-Berggren, Lisa

PY - 2015/5/19

Y1 - 2015/5/19

N2 - Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca2+ concentration ([Ca2+]i) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca2+]i response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.

AB - Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca2+ concentration ([Ca2+]i) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca2+]i response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.

KW - ApoCIII

KW - Diabetes

KW - Insulin resistance

KW - Pancreatic islets

UR - http://www.scopus.com/inward/record.url?scp=84929574372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929574372&partnerID=8YFLogxK

U2 - 10.1073/pnas.1423849112

DO - 10.1073/pnas.1423849112

M3 - Article

C2 - 25941406

AN - SCOPUS:84929574372

VL - 112

SP - E2611-E2619

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 20

ER -